Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
暂无分享,去创建一个
Keith L Black | Yosef Koronyo | Maya Koronyo-Hamaoui | K. Black | Y. Koronyo | M. Koronyo-Hamaoui | A. Rentsendorj | Altan Rentsendorj | D. Fuchs | J. Sheyn | Brenda C. Salumbides | Dieu-Trang Fuchs | Songlin Li | B. Salumbides | Brenda C Salumbides | Julia Sheyn | Lindsey Pelissier | Songlin Li | Vladimir Ljubimov | Michelle Moyseyev | David Daley | Michael Pham | V. Ljubimov | Michael Pham | Lindsey Pelissier | Michelle Moyseyev | David A. Daley
[1] S. Hickman,et al. Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice , 2008, The Journal of Neuroscience.
[2] Daniel L. Farkas,et al. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model , 2011, NeuroImage.
[3] K. Black,et al. Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline. , 2014, The Journal of clinical investigation.
[4] Tammie L. S. Benzinger,et al. Increased in Vivo Amyloid-β42 Production, Exchange, and Loss in Presenilin Mutation Carriers , 2013, Science Translational Medicine.
[5] K. Szekeres,et al. Trafficking CD11b-Positive Blood Cells Deliver Therapeutic Genes to the Brain of Amyloid-Depositing Transgenic Mice , 2010, The Journal of Neuroscience.
[6] S. Hickman,et al. Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease. , 2010, CNS & neurological disorders drug targets.
[7] Jean-Philippe Michaud,et al. Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta. , 2013, Cell reports.
[8] K. L. Richard,et al. Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid β1–42 and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease , 2008, The Journal of Neuroscience.
[9] S. Youssef,et al. Type II monocytes modulate T cell–mediated central nervous system autoimmune disease , 2007, Nature Medicine.
[10] R. Martins,et al. Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests , 2009, Molecular Psychiatry.
[11] Nathan D. Kingery,et al. Scara1 deficiency impairs clearance of soluble Amyloid-β by mononuclear phagocytes and accelerates Alzheimer’s-like disease progression , 2013, Nature Communications.
[12] M. Fornerod,et al. Characterization of the Drosophila melanogaster genome at the nuclear lamina , 2006, Nature Genetics.
[13] S. Karlsson,et al. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to β-amyloid deposition in APP/PS1 double transgenic Alzheimer mice , 2005, Neurobiology of Disease.
[14] M. Schwartz,et al. Attenuation of AD‐like neuropathology by harnessing peripheral immune cells: local elevation of IL‐10 and MMP‐9 , 2009, Journal of neurochemistry.
[15] J. McLaurin,et al. Selective targeting of perivascular macrophages for clearance of β-amyloid in cerebral amyloid angiopathy , 2009, Proceedings of the National Academy of Sciences.
[16] M. Schwartz,et al. Butovsky, O. et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl Acad. Sci. USA 103, 11784-11789 , 2006 .
[17] F. Maxfield,et al. Degradation of fibrillar forms of Alzheimer's amyloid β-peptide by macrophages , 2008, Neurobiology of Aging.
[18] P. Mcgeer,et al. Local neuroinflammation and the progression of Alzheimer’s disease , 2011, Journal of NeuroVirology.
[19] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[20] J. Relton,et al. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. , 2008, Brain : a journal of neurology.
[21] R. Arnon,et al. The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells. , 2007, Immunology letters.
[22] Tony Wyss-Coray,et al. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.
[23] Joanna L. Jankowsky,et al. Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase , 2004 .
[24] P. Lantos,et al. Astrocytosis, βA4-protein deposition and paired helical filament formation in Alzheimer's disease , 1992, Journal of the Neurological Sciences.
[25] Steffen Jung,et al. Infiltrating Blood-Derived Macrophages Are Vital Cells Playing an Anti-inflammatory Role in Recovery from Spinal Cord Injury in Mice , 2009, PLoS medicine.
[26] Tony Wyss-Coray,et al. Inflammation in Neurodegenerative Disease—A Double-Edged Sword , 2002, Neuron.
[27] S. Rivest,et al. Migration of Bone Marrow‐Derived Cells Into the Central Nervous System in Models of Neurodegeneration , 2013, The Journal of comparative neurology.
[28] W. Hickey,et al. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. , 1995, Journal of immunology.
[29] J. Koistinaho,et al. The role and therapeutic potential of monocytic cells in Alzheimer's disease , 2010, Glia.
[30] H. Weiner,et al. Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2) , 2000, The Journal of experimental medicine.
[31] H. Weiner,et al. Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease. , 2005, The Journal of clinical investigation.
[32] Shaomin Li,et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.
[33] L. Mucke,et al. TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice , 2001, Nature Medicine.
[34] J. McLaurin,et al. Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where. , 2012, Future neurology.
[35] S. Windecker,et al. Screening renal artery angiography in hypertensive patients undergoing coronary angiography and 6-month follow-up after ad hoc percutaneous revascularization , 2010, Journal of hypertension.
[36] Charles Watson,et al. Projections from the brain to the spinal cord in the mouse , 2010, Brain Structure and Function.
[37] S. Amini,et al. Monocyte chemoattractant protein-1 (MCP-1): an overview. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[38] S. Rivest,et al. Neuroprotective role of the innate immune system by microglia , 2007, Neuroscience.
[39] T. Saido. Alzheimer’s Disease as Proteolytic Disorders: Anabolism and Catabolism of β-Amyloid , 1998, Neurobiology of Aging.
[40] D. Holtzman,et al. Neuroinflammation and Alzheimer’s disease: critical roles for cytokine/Aβ-induced glial activation, NF-κB, and apolipoprotein E , 2000, Neurobiology of Aging.
[41] W. Griffin,et al. Phenotypic profile of alternative activation marker CD163 is different in Alzheimer’s and Parkinson’s disease , 2014, Acta Neuropathologica Communications.
[42] J. Julien,et al. Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease , 2006, Neuron.
[43] Michal Schwartz,et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[44] D. Cribbs,et al. Phagocytosis of Amyloid-β and Inflammation: Two Faces of Innate Immunity in Alzheimer's Disease , 2007 .
[45] S. Rivest,et al. Migration of Bone Marrow-Derived Cells Into the Central Nervous System in Models of Neurodegeneration: Naturally occurring migration of BMDC into the CNS , 2013 .
[46] F. Maxfield,et al. Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor , 1996, Neuron.
[47] R. Arnon,et al. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[48] F. Liu,et al. Macrophage-Mediated Degradation of β-Amyloid via an Apolipoprotein E Isoform-Dependent Mechanism , 2009, The Journal of Neuroscience.
[49] J. Middeldorp,et al. Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease , 2014, Neurobiology of Aging.
[50] Steffen Jung,et al. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells , 2007, The Journal of experimental medicine.
[51] Michal Schwartz,et al. Selective ablation of bone marrow‐derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model , 2007, The European journal of neuroscience.
[52] R. Ransohoff,et al. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration , 2011, Nature Neuroscience.
[53] A. Juedes,et al. Resident and Infiltrating Central Nervous System APCs Regulate the Emergence and Resolution of Experimental Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.
[54] H. Akiyama,et al. Cell mediators of inflammation in the Alzheimer disease brain. , 2000, Alzheimer disease and associated disorders.
[55] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[56] Mutsuo Takahashi,et al. Confocal observation of senile plaques in Alzheimer's disease: Senile plaque morphology and relationship between senile plaques and astrocytes , 1998, Pathology international.
[57] J. Koistinaho,et al. Animal Models of Alzheimer’s Disease: Utilization of Transgenic Alzheimer’s Disease Models in Studies of Amyloid Beta Clearance , 2012, Current Translational Geriatrics and Experimental Gerontology Reports.
[58] D. Borchelt,et al. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. , 2001, Biomolecular engineering.
[59] K. Takata,et al. Microglial transplantation increases amyloid‐β clearance in Alzheimer model rats , 2007 .
[60] C. Geula,et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease , 2007, Nature Medicine.
[61] A. Yang,et al. Complement Component C1q Modulates the Phagocytosis of Aβ by Microglia , 2000, Experimental Neurology.
[62] J. Morris,et al. Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.
[63] D. Selkoe,et al. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior , 2008, Behavioural Brain Research.
[64] G. Cole,et al. Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid. , 1992, The American journal of pathology.
[65] Michael T. Heneka,et al. PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice , 2012, The Journal of Neuroscience.
[66] J. Ringman,et al. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. , 2005, Journal of Alzheimer's disease : JAD.
[67] S. Rivest,et al. A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease. , 2013, Journal of molecular cell biology.
[68] K. Black,et al. Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimer's disease. , 2011, Investigative ophthalmology & visual science.